Read more

June 30, 2022
1 min read
Save

Top in hem/onc: Cancer survivorship; impact of COVID-19 on breast cancer care

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

According to a new report from the American Cancer Society, in collaboration with the National Cancer Institute, the number of cancer survivors in the United States has risen to 18 million.

The report highlighted ongoing issues such as poor survivorship care integration between oncology and primary care, a lack of guidelines for posttreatment care, and widespread racial disparities in treatment and survival. It was the top story in hematology/oncology last week.

Photo of person receiving chemotherapy
Source: Adobe Stock

The second top story featured an interview with Daphna Yael Spiegel, MD, MS, an assistant professor of radiation oncology at Harvard Medical School and Beth Israel Deaconess Medical Center, about breast cancer screening and delays in diagnosis during the COVID-19 pandemic.

Read these and more top stories in hematology/oncology below:

Number of cancer survivors in US rises to 18 million, disparities in care remain

As the number of cancer survivors in the U.S. tops 18 million, ensuring quality care for this aging population remains a challenge, according to a study published in CA: A Cancer Journal for Clinicians. Read more.

Lessons from COVID-19 pandemic, impact on breast cancer care

Healio spoke with Spiegel about screening, delays in diagnosis, and other ways the COVID-19 pandemic has impacted the breast cancer care continuum. Read more.

Oncologist driven by ‘passion for the mission’ of providing cancer care

Nitika Sharma, MD, said that she was driven to oncology based on a mission of providing compassionate care to patients undergoing treatment for cancer. Read more.

Systemic cancer treatment not linked to mortality among patients with COVID-19

Active systemic cancer treatment did not appear to be associated with increased mortality among patients with cancer and COVID-19, according to study results published in JAMA Network Open. Read more.

Action plan aims to improve adherence to oral anticancer therapies

Availability of oral anticancer medications has increased greatly during the past decade, offering patients the convenience of fewer appointments, less travel time and targeted treatment within the comfort of their homes. Read more.